IQVIA

Global market leader in healthcare data, analytics, and clinical research services for the life sciences industry

IQVIA Holdings, Inc. is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Formed in 2016 through the merger of IMS Health and Quintiles, IQVIA combines one of the world's largest healthcare data repositories with deep domain expertise in clinical development, real-world evidence, and commercial operations. The company serves pharmaceutical, biotechnology, and medical device companies, as well as healthcare providers and payers, across more than 100 countries. IQVIA's core offerings span data and analytics (including prescription data, patient-level data, and market intelligence), technology platforms for clinical trial management and healthcare operations, and contract research organization (CRO) services. Its proprietary IQVIA CORE platform integrates artificial intelligence, machine learning, and cloud technologies to deliver insights that help clients accelerate drug development, optimize commercial strategies, and improve patient outcomes. From a marketing and advertising perspective, IQVIA is a significant player in healthcare marketing analytics. Pharmaceutical and life sciences marketers use IQVIA's data and analytics to measure the effectiveness of their promotional campaigns, target healthcare professionals (HCPs) with precision, and optimize media spend across channels. IQVIA's Orchestrated Customer Engagement (OCE) suite and HCP targeting capabilities make it a key enabler of data-driven marketing within the regulated pharmaceutical sector.